These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 30114869)

  • 21. The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies.
    Cubie HA; Moore C; Waller M; Moss S;
    J Clin Virol; 2005 Aug; 33(4):287-92. PubMed ID: 16036178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HPV primary test in the cervical cancer screening: reproducibility assessment and investigation on cytological outcome of Hybrid Capture 2 borderline samples].
    Burroni E; Sani C; Bisanzi S; Ocello C
    Epidemiol Prev; 2016; 40(3-4):164-70. PubMed ID: 27436249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cancer: screening and prevention.
    Behtash N; Mehrdad N
    Asian Pac J Cancer Prev; 2006; 7(4):683-6. PubMed ID: 17250453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
    Hall MT; Smith MA; Lew JB; O'Hallahan J; Fentiman G; Neal H; Sage M; Canfell K
    Gynecol Oncol; 2019 Mar; 152(3):472-479. PubMed ID: 30876491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis.
    Simms KT; Laprise JF; Smith MA; Lew JB; Caruana M; Brisson M; Canfell K
    Lancet Public Health; 2016 Dec; 1(2):e66-e75. PubMed ID: 29253419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isothermal Method of a Recombinase Polymerase Amplification Assay for the Detection of Most Common High-Risk Human Papillomavirus Type 16 and Type 18 DNA.
    Ma B; Fang J; Wang Y; He H; Dai M; Lin W; Su W; Zhang M
    Clin Lab; 2017 Jan; 63(1):27-38. PubMed ID: 28164495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a pilot proficiency program for human papillomavirus DNA detection.
    Costa AG; Escott R; Garland SM; Byers D; Tabrizi SN
    Pathology; 2018 Oct; 50(6):659-664. PubMed ID: 30139535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
    Velentzis LS; Caruana M; Simms KT; Lew JB; Shi JF; Saville M; Smith MA; Lord SJ; Tan J; Bateson D; Quinn M; Canfell K
    Int J Cancer; 2017 Dec; 141(12):2410-2422. PubMed ID: 28801947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologists.
    Obermair HM; Bennett KF; Brotherton JML; Smith MA; McCaffery KJ; Dodd RH
    Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):416-423. PubMed ID: 33512715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of Australia's renewed cervical screening program: Preparedness of general practitioners and nurses.
    Sultana F; Roeske L; Malloy MJ; McDermott TL; Saville M; Brotherton JML
    PLoS One; 2020; 15(1):e0228042. PubMed ID: 31995585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renewal of the National Cervical Screening Program: health professionals' knowledge about screening of specific populations in NSW, Australia.
    Sweeney SO; Cheng Y; Botfield JR
    Public Health Res Pract; 2022 Mar; 32(1):. PubMed ID: 35291001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-collection for under-screened women in a National Cervical Screening Program: pilot study.
    Saville M; Hawkes D; Mclachlan E; Anderson S; Arabena K
    Curr Oncol; 2018 Feb; 25(1):e27-e32. PubMed ID: 29507492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new era in cervical cancer prevention.
    Roeske L
    Aust J Gen Pract; 2018 Jul; 47(7):405. PubMed ID: 30114878
    [No Abstract]   [Full Text] [Related]  

  • 36. A Thematic Analysis of Attitudes Toward Changes to Cervical Screening in Australia.
    Dodd RH; Obermair HM; McCaffery KJ
    JMIR Cancer; 2019 Apr; 5(1):e12307. PubMed ID: 30973340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National Cervical Screening Program renewal in Australia: survey of clinician views and attitudes.
    Sweeney S; Cheng Y; Botfield JR; Bateson D
    Aust J Prim Health; 2020 Oct; 26(5):410-416. PubMed ID: 32988435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comments on the article, “Primary ADN-VPH screening in women under 30 years of age: health technology assessment”.
    Campos-Ponce HF; Castro-Mamani S; Ocaña-Fernández Y
    Rev Colomb Obstet Ginecol; 2023 Mar; 74(1):90-91. PubMed ID: 37093938
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of cervical cancer screening models based on Pap and HPV tests in Tbilisi, Georgia.
    Kiguradze E; Skhirtladze T; Chkhartishvili N; Gogoladze T; Chikhladze N; Alibegashvili T
    Cent Eur J Public Health; 2024 Sep; 32(3):166-172. PubMed ID: 39352091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study.
    Bavor C; Brotherton JM; Smith MA; Prang KH; McDermott T; Rankin NM; Zammit CM; Jennett CJ; Sultana F; Machalek DA; Nightingale CE;
    BMC Health Serv Res; 2023 Oct; 23(1):1073. PubMed ID: 37803335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.